Effects of Group and Individual Culturally Adapted Cognitive Behavioral Therapy on Depression and Sexual Satisfaction among Perimenopausal Women

Khoshbooii, Robab; Hassan, Siti Aishah; Deylami, Neda; Muhamad, Rosediani; Kamarudin, Engku Mardiah Engku; Alareqe, Naser Abdulhafeeth

doi:10.3390/ijerph18147711

Cited by 5 publications

(3 citation statements)

References 63 publications

(103 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As a relevant psychometric instrument, BDI-II shows high reliability and can discriminate between depressed and non-depressed subjects for research and clinical practice worldwide ( 58 , 59 ). Therefore, using BDI-II to measure depression in perimenopausal women is well recognized, and the tool will be widely used in the future ( 60 ).…”

Section: Discussionmentioning

confidence: 99%

Global hotspots and prospects of perimenopausal depression: A bibliometric analysis via CiteSpace

et al. 2022

View full text Add to dashboard Cite

BackgroundPerimenopausal depression (PMD) is characterized by affective symptoms as well as menopause-specific somatic complaints and has attracted increasing attention over the past few decades. Using a bibliometric tool, this study aims to evaluate the origin, current hotspots, and research trends on PMD.MethodsArticles with research on PMD were retrieved from Web of Science Core Collection (WoSCC). We used the bibliometric method to analyze publication years, journals, countries, institutions, authors, research hotspots, and trends. We plotted the reference co-citation network and used keywords to analyze the research hotspots and trends.ResultsA total of 209 publications related to PMD were identified from WoSCC on May 8, 2022. The number of publications concerning PMD every year shows an upward trend. Further analysis indicated that 209 articles were contributed by 45 countries, 288 institutions, and 501 authors. The United States contributed the most significant number of publications, followed by China. Harvard University is the core institution of PMD research, and Cohen’s work has had an important impact on another research. The occurrence and pathological mechanisms of depression during the menopausal transition from the knowledge base of PMD. All of them belong to the category of gynecology and psychosis, which reflects the focus of the research topics. Major depression, postmenopausal women, symptoms like hot flashes, and prevalence and risk factors are research hotspots in the PMD field. The frontiers in PMD field that will impact future research are anxiety, meta-analysis, association, and Beck Depression Inventory-II (BDI-II).ConclusionThese findings provide us with the core countries, institutions, and authors in PMD research and point out the direction of attention in this field. The current research focuses on depression, postmenopausal women, hot flashes, and other symptoms, as well as the prevalence and risk factors. The frontiers will be anxiety, meta-analysis, related factors, and depression assessment in future research.

show abstract

Section: Discussionmentioning

confidence: 99%

Global hotspots and prospects of perimenopausal depression: A bibliometric analysis via CiteSpace

et al. 2022

View full text Add to dashboard Cite

show abstract

“…The intervention group experienced seven weekly 50–60‐min face‐to‐face group CBT sessions. The CBT program was developed by the research team after reviewing the literature and consulting with experts (Abdelaziz et al., 2022; El‐Monshed et al., 2022; Hassan et al., 2021; John et al., 2022; Kalmbach, Cheng, Arnedt, et al., 2019; Kalmbach, Cheng, Todd Arnedt, et al., 2019; Khoshbooii et al., 2021). The principal investigator and last author are trained counselors in CBT and provided all sessions to the study participants.…”

Section: Methodsmentioning

confidence: 99%

Does a program‐based cognitive behavioral therapy affect insomnia and depression in menopausal women? A randomized controlled trial

El‐Monshed,

Khonji,

Altheeb

et al. 2024

Worldviews Ev Based Nurs

View full text Add to dashboard Cite

BackgroundMenopausal women often complain of a range of physical and psychological symptoms known as menopausal syndrome. These symptoms are associated with fluctuating hormone levels, sleep disturbances, and mood swings.AimThis study aimed to examine the efficacy of a program‐based cognitive behavioral group therapy (CBT) for insomnia and depression among women experiencing menopause.MethodsA randomized controlled trial of 88 women experiencing menopause was conducted in Egypt from June to September 2022 in outpatient clinics at Mansoura University Hospitals in Egypt. Participants were randomly assigned to a control group (45 women) and an intervention group (43 women). The intervention group received 7 weeks of CBT sessions. Insomnia Severity Index (ISI), Pittsburgh Sleep Quality Index (PSQI), and Beck Depression Inventory 2nd Edition (BDI‐II) were administered before and after the intervention.ResultsIn the intervention group, there was a significant difference in scores of the subdomains of PSQI, including sleep efficiency, daytime dysfunction, subjective sleep quality, and sleep disturbance (t = 8.911, 11.77, 7.638, and 11.054, respectively), while no significant difference in domains of using sleep medication, sleep duration, and sleep latency. Significant improvements were observed between pre‐and‐post‐intervention in the intervention group for the total scores of PSQI, ISI, and BDII‐II (t = 12.711, 16.272, and 12.384, respectively), indicating a large effect size for the three studied variables (r = .81, .87, .8, respectively).Linking Evidence to ActionThis study demonstrated the efficacy of group CBT for lowering insomnia and depression in women experiencing menopause. Thus, results indicated the need of considering prompt and appropriate interventions such as CBT as a safe treatment option to prevent the aggravation of sleep and emotional problems for menopausal women.Trial RegistrationClinicalTrials.gov Identifier: NCT05920460.

show abstract

“…Psychological therapy, specifically Cognitive Behavioral Therapy (CBT), has been proposed as a low-risk treatment for menopausal symptoms with studies showing CBT as effective in reducing several common menopausal symptoms [e.g., vasomotor symptoms, depression, anxiety, and sleep difficulties; (17)(18)(19)]. Sexual concerns, however, have either not been directly targeted at all in current CBT protocols, or the two protocols that have included sessions on sexual concerns (19,20), have only demonstrated modest gains in a single domain (e.g., sexual desire).…”

Section: Introductionmentioning

confidence: 99%

Cognitive Behavioral Therapy for Sexual Concerns During Perimenopause: A Four Session Study Protocol

Green

Furtado

2021

Front. Glob. Womens Health

View full text Add to dashboard Cite

Background: During the menopausal transition, women often experience physical (e.g., vasomotor symptoms) and emotional (e.g., anxiety and depression) difficulties that significantly impact functioning and overall quality of life. Although sexual concerns (e.g., decreased sexual desire, orgasm), are reported by up to 87% of peri- and post-menopausal women, and are associated with adverse impact on functioning and distress, treatment options that directly target this area are limited, and most often involve medication (e.g., hormone replacement). Effectiveness of these treatments is often defined as improvements in physical symptoms, however, associated psychological and emotional symptoms rarely, if at all, improve. Cognitive behavioral therapy (CBT) has been proposed as a low-risk treatment for menopausal symptoms with studies showing improvement in frequently reported symptoms (e.g., vasomotor symptoms, depression, anxiety, sleep). Sexual concerns, however, have either not been directly targeted at all in current CBT protocols, or the very few protocols that include sexual concerns, demonstrated modest gains in sexual desire.Methods: This protocol paper outlines the development, design, and implementation of a newly developed CBT for sexual concerns trial during perimenopause (CBT-SC-Peri). Although sexual concerns are prevalent during both the peri- and post-menopausal periods, we will be evaluating the effectiveness of a CBT-SC protocol specifically for perimenopausal women as a means of early intervention. The clinical sample will comprise 82 women aged 40–60 years currently in perimenopause, as per the Stages of Reproductive Aging Workshop (STRAW) definition, and medication stable (if applicable). To ensure participants are experiencing clinically significant sexual concerns, a baseline cut-off score of 26 or lower on the Female Sexual Functioning Index will be utilized. Exclusion criteria include participants with psychotic disorders, or current substance and/or alcohol dependence, or severely depressed/suicidal. The CBT-SC-Peri is a weekly, four session treatment, lasting up to 90 min per session and includes psychoeducation and cognitive and behavioral strategies designed to challenge unhelpful beliefs and promote healthy sexual behaviors. As this is an individual CBT protocol, content will be tailored to address the specific problems relevant for each participant. Eligible women will be placed directly into treatment or on a 4-week waitlist and reassessed prior to starting treatment. The primary outcome (sexual satisfaction), as well as secondary outcomes (desire, arousal, relationship satisfaction, body image, vasomotor symptoms, depression, and anxiety) are assessed at baseline, post-waitlist (for those on waitlist), and post-treatment.Discussion: To our knowledge, this will be the first study to investigate the efficacy of a CBT protocol (CBT-SC-Peri) specifically aimed at improving sexual concerns experienced during perimenopause. If effective, this form of treatment may not only be preferred by some, but necessary for others as consumer demand increases for non-pharmacological treatments for perimenopausal symptoms. Further, this protocol can be integrated into perimenopausal care and will be made available by dissemination to healthcare practitioners.Clinical Trial Registration: Trial # NCT04922385 and Accessible at: https://clinicaltrials.gov/ct2/show/NCT04922385?term=NCT04922385anddraw=2andrank=1.

show abstract

Effects of Group and Individual Culturally Adapted Cognitive Behavioral Therapy on Depression and Sexual Satisfaction among Perimenopausal Women

Cited by 5 publications

References 63 publications

Global hotspots and prospects of perimenopausal depression: A bibliometric analysis via CiteSpace

Global hotspots and prospects of perimenopausal depression: A bibliometric analysis via CiteSpace

Does a program‐based cognitive behavioral therapy affect insomnia and depression in menopausal women? A randomized controlled trial

Cognitive Behavioral Therapy for Sexual Concerns During Perimenopause: A Four Session Study Protocol

Contact Info

Product

Resources

About